Nanosphere develops, manufactures and markets an advanced molecular diagnostic platform, the Verigene System, which enables simple, cost-effective, and highly sensitive nucleic acid (DNA and RNA) and protein testing on a single platform.Our breakthrough technology helps hospitals improve patient care and lowers costs by providing time-critical information, allowing earlier detection of disease and more targeted treatment. Our products have the potential to:Empower physicians to better manage infectious diseases through timely and clinically actionable diagnostic information; Enable earlier detection of life-threatening disease through ultra sensitive protein tests, while advancing the viability and clinical significance of new and existing biomarkers;Improve patient outcomes and reduce medical costs through point-of-care pharmacogenetic tests.
